Skip to main content

TABLE 1.

Specificity of BoNT/A neutralizing MAbs

MAb Isotypea BoNT serotype ELISA resultb LD50c No. live/ no. deadd
4A2-2 IgG2a A +++ 10 5/0
B ND 5 0/5
E ND 5 0/5
4A2-4 IgG2a A +++ 10 0/5
6B2-2 IgG1 A +++ 10 5/0
B ND 5 0/5
E ND 5 0/5
6C2-4 IgG1 A +++ 10 5/0
B ND 5 0/5
E ND 5 0/5
6E9-1 IgG2a A +++ 10 5/0
B ND 5 0/5
E ND 5 0/5
6E9-3 IgG2a A +++ 10 5/0
6E9-4 IgG2a A +++ 10 5/0
6E10-4 IgG2a A +++ 10 5/0
6E10-5 IgG2a A +++ 10 5/0
6E10-8 IgG2a A +++ 10 5/0
6E10-10 IgG2a A +++ 10 5/0
a

The isotypes were determined as described in the text. 

b

ELISA wells were coated with BoNT/A, BoNT/B, or BoNT/E. The MAbs were added to the wells at 100 ng/well, and bound antibodies were detected with horseradish peroxidase-labeled antibody. OD readings above 1.2 are presented as +++, while OD readings below 0.05 are shown as ND (not detected). 

c

The antibody was incubated for 1 h with 10 LD50 of BoNT/A or 5 LD50 of BoNT/B or BoNT/E before being administered to the mice. Lethality was recorded 7 days after the challenge dose. 

d

Final lethality was statistically scored using Fisher exact tests. P < 0.001 indicates protection against BoNT/A versus BoNT/B or BoNT/E.